The Effect of Dexmedetomedine on plasma concentrations of Brain-Derived Neutrophic factor

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002714

Enrollment

Unknown

Registered

2012-08-01

Start date

2012-08-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar disc protrusion

Interventions

two groups:Dexmedetomidine vs propofol

Eligibility

Sex/Gender

Male

Age

40 Years to 60 Years

Inclusion criteria

Inclusion criteria: lumbar discectomy male patients with ASA physical status I and I; aged from 40 to 60 years old; BMI from 20-30.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of alcohol abuse or antipsychotic use; 2. cardiac, pulmonary, hepatic, or renal disease; 3. patients of malnutrition or overweight whose BMI is out of the range mentioned above.

Design outcomes

Primary

Measure	Time frame
plasma concentrations of BDNF;plasma concentrations of BDNF ;	—

Contacts

Public ContactXu JM

13975148864@139.com+86 13975148864

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026